Trimovate (clobetasone/nystatin/oxytetracycline) has been relaunched as a licensed medicine by Ennogen Healthcare and is now available at an NHS list price of £12.45 for 30g.
The product was divested by the previous manufacturer in October 2017 and its subsequent lack of availability was highlighted by GPs who took part in a recent drug shortages survey by GPonline.
Trimovate is a steroid/antibiotic combination cream used to treat steroid-responsive dermatoses where candidal or bacterial infection (except due to Acinetobacter, MRSA, Pseudomonas, Proteus, Serratia or Streptococcus B) is present or likely.